Veterinary Renal Disease Market Report 2026

The veterinary renal disease market size has grown strongly in recent years. It will grow from $16.59 billion in 2025 to $17.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging pet population, late diagnosis of renal disorders in animals, limited availability of advanced renal treatments, increasing incidence of dehydration and infections, reliance on symptomatic treatment approaches.

The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $22.42 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to advancements in renal diagnostics and imaging, rising adoption of preventive screening programs, development of targeted renal medications, increasing availability of veterinary dialysis services, growing awareness of chronic kidney disease management. Major trends in the forecast period include rising prevalence of chronic kidney disease in companion animals, increasing focus on early diagnosis and routine renal screening, growing adoption of long-term renal management therapies, expansion of specialized renal treatment and dialysis services, emphasis on nutritional and supportive care for renal health.

The rise in pet ownership is expected to drive the growth of the veterinary renal disease market in the coming years. Veterinary renal disease includes conditions that affect kidney function in animals and can lead to symptoms such as increased thirst, frequent urination, reduced appetite, and weight loss. The growing prevalence of veterinary renal disease is associated with factors such as longer pet lifespans, exposure to environmental toxins, dietary influences, and genetic predispositions. Treatment approaches for veterinary renal disease typically include dietary modifications, medications, and fluid therapy to manage symptoms, slow disease progression, and enhance pets’ quality of life. For example, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, Canada was home to an estimated 7.2 million dogs and 8.2 million cats in 2024, with pets forming an essential part of more than half of Canadian households. Therefore, increasing pet ownership is contributing to the growth of the veterinary renal disease market.

Major companies operating in the veterinary renal disease market are focusing on advancing treatment and diagnostic technologies, including the development of novel diagnostic tests capable of identifying kidney injury even before clinical symptoms become evident. These diagnostic tests are designed to detect subtle changes in renal structure or function, enabling earlier intervention and helping to prevent progression to more advanced stages of kidney disease. For instance, in June 2023, IDEXX Laboratories Inc., a U.S.-based developer and manufacturer of veterinary products and services, launched the first veterinary diagnostic test for detecting kidney injury in cats and dogs. Known as the IDEXX Cystatin B Test, this innovation helps veterinarians identify kidney injury before noticeable changes in kidney function occur, supporting improved patient outcomes. The IDEXX Cystatin B Test is being incorporated into renal health test panels and is expected to provide valuable insights during approximately two million patient visits each year.

In June 2023, Mars Incorporated, a U.S.-based diversified food and pet care technology company, acquired Heska Corporation for around $1.3 billion. Through this acquisition, Mars aimed to strengthen and expand its pet health and veterinary diagnostics portfolio by increasing access to advanced diagnostic technologies, accelerating research and development efforts, and supporting a broader global network of veterinary professionals and pets. Heska Corporation is a U.S.-based healthcare technology company specializing in advanced veterinary diagnostic and specialty products and solutions.

Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Veterinary Transplant Services Inc., Kibow Biotech Inc.

North America was the largest region in the veterinary renal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary renal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the veterinary renal disease market by increasing costs of imported diagnostic equipment, medications, and dialysis systems, influencing treatment affordability and access. Regions such as north america and europe are most impacted due to dependence on specialized imported renal care technologies. Segments including diagnostic imaging, dialysis, and advanced medications have faced cost pressures, while tariffs have encouraged local manufacturing, regional sourcing, and development of cost-effective renal treatment solutions. Overall, tariffs have driven supply chain diversification and localized production efforts.

The veterinary renal disease market research report is one of a series of new reports that provides veterinary renal disease market statistics, including veterinary renal disease industry global market size, regional shares, competitors with a veterinary renal disease market share, detailed veterinary renal disease market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary renal disease industry. This veterinary renal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary renal disease encompasses a range of conditions that affect the kidneys of animals, resulting in impaired kidney function. This disruption affects the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues.

The main types of veterinary renal disease involve diagnosis and treatment. Diagnosis involves reaching a conclusion through medical evaluation, identifying specific conditions or diseases affecting an individual animal's health. The types of animals affected include canine, feline, bovine, equine, and others, with indications such as renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, among others. Treatment can be administered via injectable or oral routes and products are distributed through pharmacies, pet specialty stores, e-commerce platforms, and other channels.

The veterinary renal disease market consists of revenues earned by entities by providing services such as laboratory testing, imaging services, and fluid therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary renal disease market also includes sales of angiotensin receptor blockers, phosphate binders, omega-3 fatty acids, and antioxidants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.